RIPK3 and cholangiocarcinoma: In contrast, the expression levels of RIP3 in 42 cases of CCA tissues was 13 cases with negative expression (31.0%), 25 cases with low expression (59.5%) and 4 cases with strong expression (9.5%; Figure 6 and Table 1).